Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071677 · ClinicalTrials.gov registry record
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT05071677: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT05071677 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05071677 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information sources that support this decision-making process.
Interventions
- OTHER Survey Administration
- OTHER Interview
- PROCEDURE Discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2023-08-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05071677
The ClinicalTrials.gov registry entry for NCT05071677 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT05071677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05071677 about?
NCT05071677 is a clinical study titled "Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer". This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information sources that support this decision-making process.
What is the current status of trial NCT05071677?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-05-03. Estimated completion is 2023-08-07.
What interventions are being tested in trial NCT05071677?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT05071677?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.